磁共振弹性成像与瞬时弹性成像对非酒精性脂肪性肝病患者肝纤维化分期的比较:系统评价与个体参与者数据的汇总分析
该研究系统检索2005至2017年文献,纳入3项同时行磁共振弹性成像(MRE)、瞬时弹性成像(TE)和肝活检的成人非酒精性脂肪性肝病(NAFLD)研究,汇总230例活检证实NAFLD患者个体数据。以肝活检为参考,MRE检测各期纤维化的AUROC均显著高于TE。
要点
- 汇总230例活检证实NAFLD患者,MRE检测纤维化各期的AUROC均高于TE。
- 检测纤维化≥1期:TE的AUROC为0.82,MRE为0.87(P=.04)。
- 检测纤维化≥2期:TE的AUROC为0.87,MRE为0.92(P=.03)。
核心结论
- 在活检证实NAFLD患者的个体数据汇总分析中,MRE检测各期肝纤维化的诊断准确性在统计学上显著高于TE。
- MRE和TE在NAFLD患者纤维化检测中各有其作用,取决于所需准确度水平。
研究设计与样本
- 系统检索2005年至2017年发表文献,纳入3项同时行MRE、TE和肝活检的成人NAFLD研究。
- 汇总分析纳入230例活检证实NAFLD的个体参与者数据,平均年龄52.2±13.9岁,体重指数31.9±7.5 kg/m2。
- 计算MRE和TE检测各期纤维化的聚类调整受试者工作特征曲线下面积(AUROC),采用DeLong检验比较两者AUROC。
主要发现
- 纤维化0、1、2、3、4期患者比例分别为31.7%、27.8%、15.7%、13.9%和10.9%。
- 检测纤维化≥1期:TE的AUROC为0.82(95% CI,0.76-0.88),MRE为0.87(95% CI,0.82-0.91),P=.04。
- 检测纤维化≥2期:TE的AUROC为0.87(95% CI,0.82-0.91),MRE为0.92(95% CI,0.88-0.96),P=.03。
- 检测纤维化≥3期:TE的AUROC为0.84(95% CI,0.78-0.90),MRE为0.93(95% CI,0.89-0.96),P=.001。
- 检测纤维化≥4期:TE的AUROC为0.84(95% CI,0.73-0.94),MRE为0.94(95% CI,0.89-0.99),P=.005。
临床怎么用
- 作者认为MRE和TE在NAFLD患者纤维化检测中各有其作用,取决于所需准确度水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Magnetic resonance elastography (MRE) and transient elastography (TE) are noninvasive techniques for detection of liver fibrosis. Single-center studies have compared the diagnostic performance of MRE vs TE in patients with nonalcoholic fatty liver disease (NAFLD). We conducted a pooled analysis of individual participant data from published studies to compare the diagnostic performance of MRE vs TE for staging of liver fibrosis in patients with NAFLD, using liver biopsy as reference. METHODS: We performed a systematic search of publication databases, from 2005 through 2017. We identified 3 studies of adults with NAFLD who were assessed by MRE, TE, and liver biopsy. In a pooled analysis, we calculated the cluster-adjusted area under the curve (AUROC) of MRE and TE for the detection of each stage of fibrosis. AUROC comparisons between MRE and TE were performed using the Delong test. RESULTS: Our pooled analysis included 230 participants with biopsy-proven NAFLD with mean age of 52.2±13.9 years and a body mass index of 31.9±7.5 kg/m2. The proportions of patients with fibrosis of stages 0, 1, 2, 3, and 4 were: 31.7%, 27.8%, 15.7%, 13.9%, and 10.9%, respectively. The AUROC of TE vs MRE for detection of fibrosis stages ≥1 was 0.82 (95% CI, 0.76-0.88) vs 0.87 (95% CI, 0.82-0.91) (P=.04); for stage≥ 2 was 0.87 (95% CI, 0.82-0.91) vs 0.92 (95% CI, 0.88-0.96) (P=.03); for stage ≥3 was 0.84 (95% CI, 0.78-0.90) vs 0.93 (95% CI, 0.89-0.96) (P=.001); for stage ≥ 4 was 0.84 (95% CI, 0.73-0.94) vs 0.94 (95% CI, 0.89-0.99) (P=.005). CONCLUSION: In a pooled analysis of data from individual participants with biopsy-proven NAFLD, we found MRE to have a statistically significantly higher diagnostic accuracy than TE in detection of each stage of fibrosis. MRE and TE each have roles in detection of fibrosis in patients with NAFLD, depending upon the level of accuracy desired.
引用
- Hsu C, Caussy C, Imajo K, et al. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol. 2018. PMID: 29908362. doi:10.1016/j.cgh.2018.05.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。